scholarly journals IP021. Aspartate Aminotransferase to Platelet Ratio Index Score Predicts Morbidity and Mortality Following Endovascular Aneurysm Repair Among Patients With Liver Disease

2019 ◽  
Vol 69 (6) ◽  
pp. e115-e116
Author(s):  
Sara L. Zettervall ◽  
Kirsten Dansey ◽  
Nicholas J. Swerdlow ◽  
Marc L. Schermerhorn
Keyword(s):  
Liver Disease ◽  
Aspartate Aminotransferase ◽  
Endovascular Aneurysm Repair ◽  
Index Score ◽  
Morbidity And Mortality ◽  
Aneurysm Repair

Comparison of Aortomonoiliac Endovascular Aneurysm Repair Versus a Bifurcated Stent-Graft: Analysis of Perioperative Morbidity and Mortality

2009 ◽  
Vol 16 (3) ◽  
pp. 295-301 ◽  
Author(s):  
Ayesha Noorani ◽  
David G. Cooper ◽  
Stewart R. Walsh ◽  
Umar Sadat ◽  
Kevin Varty ◽  
...  
Keyword(s):  
Stent Graft ◽  
Endovascular Aneurysm Repair ◽  
Morbidity And Mortality ◽  
Perioperative Morbidity ◽  
Aneurysm Repair

Endovascular repair for abdominal aortic aneurysms

Heart ◽  
2021 ◽  
pp. heartjnl-2020-318288
Author(s):  
Samuel Debono ◽  
Jennifer Nash ◽  
Andrew L Tambyraja ◽  
David E Newby ◽  
Rachael O Forsythe
Keyword(s):  
Endovascular Aneurysm Repair ◽  
Abdominal Aortic Aneurysms ◽  
Aortic Aneurysms ◽  
Morbidity And Mortality ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Abdominal Aortic ◽  
Risk Of Rupture ◽  
Aneurysm Repair ◽  
Selection Of

Management of abdominal aortic aneurysms has been the subject of rigorous scientific scrutiny. Prevalence studies have directed the formation of screening programmes, and observational studies and randomised controlled trials have defined aneurysm growth and treatment thresholds. Pre-emptive intervention with traditional open surgical repair has been the bedrock of improving long-term outcome and survival in patients with abdominal aortic aneurysms but it is associated with a significant procedural morbidity and mortality. Endovascular aneurysm repair (EVAR) has substantially reduced these early complications and has been associated with promising results in both elective and emergency aneurysm repair. However, the technique has brought its own unique complications, endoleaks. An endoleak is the presence of blood flow within the aneurysm sac but outside the EVAR graft. Although in randomised control trials EVAR was associated with a reduced early mortality compared with open repair, its longer-term morbidity and mortality was higher because endoleak development is associated with a higher risk of rupture. These endoleak complications have necessitated the development of postoperative imaging surveillance and re-intervention. These contrasting benefits and risks inform the selection of the mode of repair and are heavily influenced by individual patient factors. An improved strategy to predict endoleak development could further help direct treatment choice for patients and improve both early and late outcomes. This article reviews current EVAR practice, recent updates in clinical practice guidelines and the potential future developments to facilitate the selection of mode of aneurysm repair.Trial registration number: ClinicalTrials.gov NCT04577716.

scholarly journals NESVS11. Fenestrated Endovascular Aneurysm Repair Is Associated With Lower Perioperative Morbidity and Mortality Compared with Open Juxtarenal Aneurysm Repair

2018 ◽  
Vol 68 (4) ◽  
pp. e102-e103 ◽  
Author(s):  
Rens R.B. Varkevisser ◽  
Thomas F.X. O’Donnell ◽  
Nicholas J. Swerdlow ◽  
Patric Liang ◽  
Chun Li ◽  
...  
Keyword(s):  
Endovascular Aneurysm Repair ◽  
Morbidity And Mortality ◽  
Perioperative Morbidity ◽  
Aneurysm Repair ◽  
Juxtarenal Aneurysm

scholarly journals Complications and Management of the Thoracic Endovascular Aortic Repair

Aorta ◽  
2020 ◽  
Vol 08 (03) ◽  
pp. 049-058
Author(s):  
Sheena W. Chen ◽  
Kyongjune B. Lee ◽  
Michael A. Napolitano ◽  
Alejandro E. Murillo-Berlioz ◽  
Anna P. Sattah ◽  
...  
Keyword(s):  
Aortic Aneurysm ◽  
Thoracic Aortic Aneurysm ◽  
Spinal Cord Ischemia ◽  
Prospective Trial ◽  
Endovascular Aneurysm Repair ◽  
The United States ◽  
Morbidity And Mortality ◽  
Descending Thoracic Aortic Aneurysm ◽  
Aortic Repair ◽  
Aneurysm Repair

AbstractEndovascular treatment in thoracic aortic diseases has increased in use exponentially since Dake and colleagues first described the use of a home-made transluminal endovascular graft on 13 patients with descending thoracic aortic aneurysm at Stanford University in the early 1990s. Thoracic endovascular aneurysm repair (TEVAR) was initially developed for therapy in patients deemed unfit for open surgery. Innovations in endograft engineering design and popularization of endovascular techniques have transformed TEVAR to the predominant treatment choice in elective thoracic aortic repair. The number of TEVARs performed in the United States increased by 600% from 1998 to 2007, while the total number of thoracic aortic repairs increased by 60%. As larger multicenter trials and meta-analysis studies in the 2000s demonstrate the significant decrease in perioperative morbidity and mortality of TEVAR over open repair, TEVAR became incorporated into standard guidelines. The 2010 American consensus guidelines recommend TEVAR to be “strongly considered” when feasible for patients with degenerative or traumatic aneurysms of the descending thoracic aorta exceeding 5.5 cm, saccular aneurysms, or postoperative pseudoaneurysms. Nowadays, TEVAR is the predominant treatment for degenerative and traumatic descending thoracic aortic aneurysm repair. Although TEVAR has been shown to have decreased early morbidity and mortality compared with open surgical repair, endovascular manipulation of a diseased aorta with endovascular devices continues to have significant risks. Despite continued advancement in endovascular technique and devices since the first prospective trial examined the complications associated with TEVAR, common complications, two decades later, still include stroke, spinal cord ischemia, device failure, unintentional great vessel coverage, access site complications, and renal injury. In this article, we review common TEVAR complications with some corresponding radiographic imaging and their management.

Bowel ischaemia after endovascular aneurysm repair

VASA ◽  
2018 ◽  
Vol 47 (4) ◽  
pp. 273-277
Author(s):  
Christopher Lowe ◽  
Oussama El Bakbachi ◽  
Damian Kelleher ◽  
Imran Asghar ◽  
Francesco Torella ◽  
...  
Keyword(s):  
Case Reports ◽  
Endovascular Aneurysm Repair ◽  
Artery Occlusion ◽  
Bibliographic Databases ◽  
Bowel Ischaemia ◽  
Prophylactic Measures ◽  
Increased Risk ◽  
Prisma Statement ◽  
Meta Analyses ◽  
Aneurysm Repair

Abstract. The aim of this review was to investigate presentation, aetiology, management, and outcomes of bowel ischaemia following EVAR. We present a case report and searched electronic bibliographic databases to identify published reports of bowel ischaemia following elective infra-renal EVAR not involving hypogastric artery coverage or iliac branch devices. We conducted our review according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement standards. In total, five cohort studies and three case reports were included. These studies detailed some 6,184 infra-renal elective EVARs, without procedure-related occlusion of the hypogastric arteries, performed between 1996 and 2014. Bowel ischaemia in this setting is uncommon with an incidence ranging from 0.5 to 2.8 % and includes a spectrum of severity from mucosal to transmural ischaemia. Due to varying reporting standards, an overall proportion of patients requiring bowel resection could not be ascertained. In the larger series, mortality ranged from 35 to 80 %. Atheroembolization, hypotension, and inferior mesenteric artery occlusion were reported as potential causative factors. Elderly patients and those undergoing prolonged procedures appear at higher risk. Bowel ischaemia is a rare but potentially devastating complication following elective infra-renal EVAR and can occur in the setting of patent mesenteric vessels and hypogastric arteries. Mortality ranges from 35 to 80 %. Further research is required to identify risk factors and establish prophylactic measures in patients that have an increased risk of developing bowel ischaemia after standard infra-renal EVAR.

Laser-assisted transprosthesial coil embolization combined with thrombin injection for treatment of an endoleak type II after endovascular aneurysm repair

VASA ◽  
2018 ◽  
Vol 47 (1) ◽  
pp. 63-67 ◽  
Author(s):  
Tanja Boehme ◽  
Aljoscha Rastan ◽  
Elias Noory ◽  
Peter-Christian Fluegel ◽  
Thomas Zeller
Keyword(s):  
Coil Embolization ◽  
Endovascular Aneurysm Repair ◽  
Type Ii ◽  
Thrombin Injection ◽  
Endoleak Type Ii ◽  
Aneurysm Repair

Abstract. The treatment of endoleaks type II had to be adapted to the anatomy of each individual patient. The laser-assisted perforation of the prosthesis can be an easier method to reach the aneurysm sac directly than using transarterial or translumbar approaches.

Sign in / Sign up

Export Citation Format

Share Document